CD274 and neoplasm: Surprisingly, antibodies targeting the PD-1/PD-L1 immune checkpoint axis reversed T cell exhaustion and led to paradoxical enhancement of anti-tumor immunity in both obese mouse models and humans (Wang et al, 2019; Dyck et al, 2022).